Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DR26F1H35
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract utilizes firm fixed pricing with an ultimate completion date of December 5, 2025, and is not set-aside, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a broad range of medications and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs across multiple therapeutic domains through competitively awarded delivery orders with the DLA. The current order for Vyndamax, a neurological medication, exemplifies the company's role in supplying specialized brand-name pharmaceuticals essential to military medical operations. DLA Troop Support's planned Pharmaceutical Prime Vendor Global Program Generation V initiative indicates potential for multiple regional contract awards, underscoring the strategic importance of vendors like AmerisourceBergen in supporting U.S. military healthcare supply chains.
Quick answers
Who was awarded contract SPE2DR26F1H35?
SPE2DR26F1H35 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F1H35 worth?
The government has obligated $14,593 on SPE2DR26F1H35.
Is contract SPE2DR26F1H35 an order under another contract?
Yes. SPE2DR26F1H35 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1H35 competed?
The extent of competition for SPE2DR26F1H35 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award